CompoAtlas

Ultraquin Plain 4% Hydroquinone Cream USP

Testo originale in francese.

Prodotto naturale per la salute autorizzato in Canada

L’analisi delle dosi orali non si applica senza una via esclusivamente orale accertata.

Composizione

Ingrediente medicinale e fontePer unità posologica, secondo la fonte
Hydroquinone4 % (p/p)

Ingredienti non medicinali

Octyldodecyl Stearoyl Stearate, Métabisulfite de sodium, Eau purifiée, Chlorure de benzalkonium, propylèneglycol, Mineral oil, PolyDimethylsiloxane / Polymethylsilesquioxane Copolymer, Octyl Palmitate, Hydroxy methyl cellulose, EDTA de sodium, Acide ascorbique, Emulgate PL 68-50, Stéarate de glycéryle, Quaternium - 15, Acide phosphorique

Dosi raccomandate in Canada

PopolazioneEtàQuantità per assunzioneFrequenza
AdultesNon préciséeNon préciséeminimum : 1 Tous les jours ; maximum : 2 Tous les jours
Enfantsminimum : 12 ansNon préciséeminimum : 1 Tous les jours ; maximum : 2 Tous les jours

Usi autorizzati in Canada

To lighten hyperpigmented skin, fade skin discolorations and lighten freckles and " age spots".

Testo originale in francese.

Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.

Avvertenze in Canada

Cautions and Warnings : To be used only on the advice of a physician. For external use only. Use only as directed. Avoid contact with eyes, mucous membranes and broken or irritated skin. In case of contact, rinse thoroughly with water. Do only apply over sunburn or irritated skin. Test for sensitivity. Apply only to small skin surface area. Discontinue sue and consult a physician in case of skin reactions or a blue-black darkening of the skin. A mild transient stinging or minor redness may occur in people with sensitive skin. To test for sensitivity, before treatment, apply to n an area of approximately 1 cm2 of unbroken skin on the inside of the arm. If no irritation occurs within 24 hours, begin treatment for up to 12 weeks. Discontinue sue in case of irritation, rash, excessive inflammatory response or if gradual blue-black darkening of the skin (exogenous ochronosis) occurs. Minor redness is acceptable, but where there is an excessive irritation, a rash or other reaction, further treatment is not advised. Severe itching or reddening may occur, in which case the product should be discontinued and the physician notified immediately. The safety of topical hydroquinone use during pregnancy or children 12 years old or less has not been established. Do not use this product if you have used it or any of its ingredients before and skin sensitivity or irritation has occurred. Do not use this product if you are nursing, pregnant or if you intend to become pregnant within 3 months of use. If you have a family history or, have or have had or at risk of developing cancer, do not use. Hydroquinone is a skin bleaching agent which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this product. Close patient supervision is recommended. A bitter taste and anesthetic effect may occur if applied to lips. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure may cause skin re-darkening. Treatment should be limited to relatively small areas of the body at one time. Keep out of reach of children. Not for use on children under 12 years of age. In case of accidental ingestion, seek medical assistance or contact Poison Control Center immediately. Note: Slight darkening of the product is normal when exposed to air and does not affect its potency. When this happens, extract a tiny amount of product, clean with a cotton swab and discard prior to use. If the entire contents become brown, discontinue use and consult a physician. Store at room temperature.

Testo originale in inglese.

Scheda del prodotto

Titolare
Opella Canada Inc.
NPN o DIN-HM
00632783
Stato
Licenza non attiva
Data della licenza
11 gennaio 2008
Data di revisione
8 aprile 2014
Forma
Crème
Via di somministrazione
Topique
Tipo di domanda
DIN de transition

Fonte

Scheda ufficiale Health Canada, licenza 00632783

Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Testo originale in inglese.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Testo originale in francese.

La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.

Elenco nella revisione ufficiale del (registro: Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze).

Fotografare la confezione

Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.

Elenco rilevato nel 2014. Fotografi la confezione per verificare eventuali modifiche.

Invio per analizzare, Maiusc+Invio per una nuova riga